Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 2116 (MIR2116), also known as hsa-mir-2116, is a putative human microRNA gene annotated in sequence databases like miRBase. MicroRNAs are small, non-coding RNAs involved in the post-transcriptional regulation of gene expression, typically functioning via base pairing with complementary sequences in target mRNAs to induce silencing through mRNA degradation or translational repression[3][4][5]. However, there is currently no published functional or clinical literature specifying unique biological activities, validated targets, disease associations, or therapeutic relevance for MIR2116. It is not considered a well-established therapeutic target, nor is there evidence of it being biomarker or drug interaction partner. The lack of any substantial functional studies, experimental characterizations, or disease-linking publications indicates that MIR2116 is currently only defined bioinformatically and its biological relevance remains unconfirmed.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 2116 (MIR2116).